Lung Cancer Health Center

Citations

1. American Cancer Society (2009). Cancer Facts and Figures 2009. Atlanta: American Cancer Society. Available online: http://www.cancer.org/acs/groups/content/@nho/documents/document/500809webpdf.pdf.

2. Ettinger DS (2008). Lung cancer and other pulmonary neoplasms. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 1456-1465. Philadelphia: Saunders Elsevier.

3. Rivera MP (2009). Lung cancer in women: The difference in epidemiology, biology and treatment outcomes. Expert Review of Respiratory Medicine, 3(6): 627-634.

4. National Toxicology Program, U.S. Department of Health and Human Services (2005). Report on Carcinogens, 11th ed. Available online: http://ntp-server.niehs.nih.gov/ntp/roc/toc11.html.

5. National Comprehensive Cancer Network (2010). Non-Small Cell Lung Cancer, version 2.2010. Available online: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

6. Aldington S, et al. (2008). Cannabis use and risk of lung cancer: A case-control study. European Respiratory Journal, 31(2): 280-286.

7. Fox JL, et al. (2004). The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer, 44(3): 287-293.

8. Dasgupta P, et al. (2006). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proceedings of the National Academy of Sciences, 103(16): 6332-6337.

9. Cassileth BR, et al. (2007). Complementary therapies and integrative oncology in lung cancer. Chest, 132: 340S-354S.

10. Temel JS, et al. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. New England Journal of Medicine, 363(8): 733-742.

11. Crawford J (2007). Lung cancer. In DC Dale, DD Federman, eds., ACP Medicine, section 12, chap. 8. New York: WebMD.

12. Godtfredsen NS, et al. (2005). Effect of smoking reduction on lung cancer risk. JAMA, 294(12): 1505-1510.

13. Goodman GE, et al. (2004). The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. Journal of the National Cancer Institute, 96(23): 1743-1750.

Other Works Consulted

• Abramowicz M (2003). Treatment guidelines: Drugs of choice for cancer. Medical Letter on Drugs and Therapeutics, 1(7): 41-52.

• Detterbeck FC, et al. (2009). Special feature: The new lung cancer staging system. Chest, 136: 260-271.

• Erlotinib (Tarceva) for advanced non-small cell lung cancer (2005). Medical Letter on Drugs and Therapeutics, 47(1205): 25-27.

• National Cancer Institute (2009). Small Cell Lung Cancer PDQ: Treatment - Patient Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/Patient.

• National Cancer Institute (2010). Non-Small Cell Lung Cancer PDQ: Treatment - Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/healthprofessional/HealthProfessional.

• National Cancer Institute (2010). Non-Small Cell Lung Cancer PDQ: Treatment - Patient Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/patient.

• National Cancer Institute (2010). Small Cell Lung Cancer PDQ: Treatment - Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/HealthProfessional.

• Neville A (2009). Lung cancer, search date May 2008. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.

• Pemetrexed (Alimta) for mesothelioma (2004). Medical Letter on Drugs and Therpeutics, 46(1180): 31-32.

• Schwartz DA (2007). Occupational and environmental lung disease. In DC Dale, DD Federman, eds., ACP Medicine, section 14, chapter 18. New York: WebMD.